Avantor, Inc. Preferred Stock Dividends, Income Statement Impact
Avantor, Inc. (AVTR) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2025-02-07
- Avantor, Inc. preferred stock dividends, income statement impact for the quarter ending 2023-12-31 was $0.00.
- Avantor, Inc. preferred stock dividends, income statement impact for the quarter ending 2023-09-30 was $0.00.
- Avantor, Inc. preferred stock dividends, income statement impact for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Avantor, Inc. preferred stock dividends, income statement impact for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Avantor, Inc. preferred stock dividends, income statement impact for fiscal 2024 was $0.00.
- Avantor, Inc. preferred stock dividends, income statement impact for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Avantor, Inc. preferred stock dividends, income statement impact for fiscal 2022 was $24.20M, a 62.54% decline from fiscal 2021.
- Avantor, Inc. preferred stock dividends, income statement impact for fiscal 2021 was $64.60M, a 0.00% change from fiscal 2020.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-07 | $0.00 10-K · filed 2025-02-07 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $0.00 10-Q · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-07 | $8.10M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-07 | $8.10M derived: sum of 3 quarters · filed 2025-02-07 | $24.20M 10-K · filed 2025-02-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-27 | $8.10M derived: sum of 2 quarters · filed 2023-10-27 | $24.20M 10-Q · filed 2023-10-27 | $40.40M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $8.10M 10-Q · filed 2023-07-28 | $24.20M 10-Q · filed 2023-07-28 | $40.40M derived: sum of 3 quarters · filed 2024-02-14 | $56.50M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $16.10M 10-Q · filed 2023-04-28 | $32.30M derived: sum of 2 quarters · filed 2024-02-14 | $48.40M derived: sum of 3 quarters · filed 2024-02-14 | $64.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $32.30M derived: sum of 2 quarters · filed 2024-02-14 | $48.50M derived: sum of 3 quarters · filed 2024-02-14 | $64.60M 10-K · filed 2024-02-14 |
| 2021-09-30 | $16.10M 10-Q · filed 2022-10-28 | $32.30M derived: sum of 2 quarters · filed 2022-10-28 | $48.40M 10-Q · filed 2022-10-28 | $64.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $16.20M 10-Q · filed 2022-07-29 | $32.30M 10-Q · filed 2022-07-29 | $48.50M derived: sum of 3 quarters · filed 2023-02-14 | $64.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $16.10M 10-Q · filed 2022-04-29 | $32.30M derived: sum of 2 quarters · filed 2023-02-14 | $48.40M derived: sum of 3 quarters · filed 2023-02-14 | $64.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $32.30M derived: sum of 2 quarters · filed 2023-02-14 | $48.50M derived: sum of 3 quarters · filed 2023-02-14 | $64.60M 10-K · filed 2023-02-14 |
| 2020-09-30 | $16.10M 10-Q · filed 2021-10-29 | $32.30M derived: sum of 2 quarters · filed 2021-10-29 | $48.40M 10-Q · filed 2021-10-29 | $64.50M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $16.20M 10-Q · filed 2021-07-30 | $32.30M 10-Q · filed 2021-07-30 | $48.40M derived: sum of 3 quarters · filed 2022-02-11 | $64.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $16.10M 10-Q · filed 2021-04-28 | $32.20M derived: sum of 2 quarters · filed 2022-02-11 | $48.60M derived: sum of 3 quarters · filed 2022-02-11 | $96.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $32.50M derived: sum of 2 quarters · filed 2022-02-11 | $80.70M derived: sum of 3 quarters · filed 2022-02-11 | $152.50M 10-K · filed 2022-02-11 |
| 2019-09-30 | $16.40M 10-Q · filed 2020-10-27 | $64.60M derived: sum of 2 quarters · filed 2020-10-27 | $136.40M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $48.20M 10-Q · filed 2020-07-29 | $120.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $71.80M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $269.50M 10-K · filed 2021-02-16 | |||
| 2017-12-31 | $27.80M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |